News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
18-Oct-2006 - Geron Corporation announced the appointment of Alan B. Colowick, M.D., M.P.H., as president, oncology. In this newly created position, Dr. Colowick, 44, will manage the operational and strategic activities of the company's oncology programs. He will report to Dr. Thomas Okarma, Geron's president ...
17-Oct-2006 - The Debiopharm Group and Cambridge Antibody Technology (CAT) have entered into an exclusive worldwide licensing agreement to develop and commercialise SC-1 and all derivative products generated by the use of the SC-1 Technology. SC-1, developed by Debiopharm, is a fully human monoclonal IgM ...
17-Oct-2006 - Biovitrum has initiated a clinical Phase II study with the candidate drug BVT.28949, a 5-HT2A antagonist for the treatment glaucoma. The results are expected to be available midyear of 2007. The Phase II study includes 150 patients with an elevated intraocular pressure (a hallmark of glaucoma) ...
17-Oct-2006 - Ark Therapeutics Group plc announced that the European Patent Office has granted the Company a patent covering the use of Cerepro, its novel gene-based medicine for the treatment of operable high grade glioma (brain cancer). The patent grant gives protection in Europe until November 2019. Cerepro ...
New Genta Pipeline Drug Targets Master Regulatory Gene for Cancer Cell Growth
17-Oct-2006 - Genta Incorporated announced initiation of a Phase 1 clinical trial using an anticancer drug derived from the Company's DNA/RNA Medicines program. The new compound, known as G4460, uses antisense technology to target an oncogene known as c-myb that regulates key functions in cancer cells. Using ...
16-Oct-2006 - Genentech, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) to be used in combination with carboplatin and paclitaxel chemotherapy for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous, ...
12-Oct-2006 - MediGene AG announced that the European Medicines Agency (EMEA) has recommended granting of orphan drug designation for MediGene's drug candidate EndoTAG-1 in the indication pancreatic cancer. This recommendation is subject to the European Commission's approval. Dr. Peter Heinrich, Chief ...
12-Oct-2006 - Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer´s disease, according to new findings from Karolinska Institutet (KI) in Sweden. However, the positive affect of Omega-3 do not appear in cases with more advanced Alzheimer´s. Several studies have ...
12-Oct-2006 - Stem Cell Innovations, Inc. announced that the Company will collaborate with Massachusetts Eye and Ear Infirmary (MEEI). Under the material transfer agreement, MEEI will evaluate PluriCells for their capacity to form the human tissues implicated in hearing loss. In return SCI will receive a ...
Work could significantly impact medicine
11-Oct-2006 - MIT and Hong Kong University researchers have shown that some simple biodegradable liquids can stop bleeding in wounded rodents within seconds, a development that could significantly impact medicine. When the liquid, composed of peptides, is applied to open wounds, the peptides self-assemble into ...
© 1997-2024 LUMITOS AG, All rights reserved